Latest News

• share
• favorite_border

Esteemed clinicians and researchers recognized for their contributions to American Thyroid Association, thyroid cancer and thyroid disease research.

• share
• favorite_border

The American Thyroid Association (ATA) celebrates the recipients of the Women Advancing Thyroid Research Award.  This award recognizes and honors the work of young women that are leading outstanding thyroid research.

• share
• favorite_border

American Thyroid Association releases new guidelines for the diagnosis, evaluation, and treatment of anaplastic thyroid cancer.

• share
• favorite_border

American Thyroid Association to host ATA Alliance for Thyroid Patient Education Health Forum on Saturday, November 14, 2020 from noon - 1:15pm EST. Clinicians, Patient Advocates, Patients, and Families invited to participate.

• share
• favorite_border

The new Executive Director replaces a legacy leader who has served the ATA for 24 years.

• share
• favorite_border

For the first time in its 96-year history, the American Thyroid Association (ATA) will be majority led by a president, secretary/COO, treasurer, and past-president who are women.  The ATA, headquartered in Falls Church, VA, announces with pleasure that Martha Zeiger, MD, began a one-year term as president of the Board of Directors and Jacqueline Jonklaas, MD, started her 4-year term as Secretary/Chief Operating Officer at the close of the 89th Annual Meeting, November 3 in Chicago, Illinois.

• share
• favorite_border

The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019, at the Sheraton Grand Chicago in Chicago, Illinois.

• share
• favorite_border

November 1, 2019—The American Thyroid Association (ATA) is pleased to announce that the Distinguished Service Award recipient will be Dr. Robert C. Smallridge. He is Professor of Medicine at Mayo Medical School and the Alfred D. and Audrey M. Petersen Professor of Cancer Research.  He is a Deputy Director in the Mayo Clinic Cancer Center and has served as the Chair of the Division of Endocrinology, the Director of Research, and as a member of the  Board of Governors.

• share
• favorite_border

November 1, 2019—The American Thyroid Association (ATA) is pleased to announce that the 2019 Sidney H. Ingbar Distinguished Lectureship Award recipient will be Dr. Bryan R. Haugen, currently is Professor of Medicine and Pathology at the University of Colorado Denver. He is also Chief of the Division of Endocrinology, Metabolism & Diabetes and Director of the Thyroid Tumor Program and holds the Mary Rossick Kern and Jerome H.

• share
• favorite_border

November 1, 2019—The American Thyroid Association (ATA) announces with pleasure that the 2019 John B. Stanbury Thyroid Pathophysiology Medal will be awarded to Dr. Sissy M. Jhiang at the ATA Annual Meeting this week. Dr. Jhiang is the Professor of Physiology and Cell Biology at the Ohio State University (OSU), member of the OSU Comprehensive Cancer Center and Graduate Faculty member for multiple graduate programs.

• share
• favorite_border

November 2, 2019—The American Thyroid Association (ATA) announces with pleasure that the 2019 Lewis E. Braverman Distinguished Award recipient will be Dr. Martha A. Zeiger, Director of Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.The Braverman Distinguished Award is presented annually to an individual who: demonstrates excellence and passion for mentoring fellows, students, and junior faculty; has a long history of productive thyroid research; and is devoted to the ATA.

• share
• favorite_border

October 31, 2019 — The American Thyroid Association (ATA) announces with pleasure that the prestigious Van Meter Award for 2019 has been presented to Dr. Cari Kitahara, a tenure-track Investigator at the National Cancer Institute, National Institutes of Health in Bethesda, Maryland.  Dr. Kitahara earned her doctoral (2011) and master’s (2008) degrees in cancer epidemiology from the Johns Hopkins Bloomberg School of Public Health.

• share
• favorite_border

The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019, at the Sheraton Grand Chicago in Chicago, Illinois. In addition to hearing major speeches and awards, attendees can view the following posters and oral presentations on disorders of thyroid dysfunction.###The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.

• share
• favorite_border

The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019, at the Sheraton Grand Chicago in Chicago, Illinois. In addition to hearing major speeches and awards, attendees can view the following posters and oral presentations on thyroid imaging and thyroid nodules and goiter.###The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.

• share
• favorite_border

October 31, 2019 —The American Thyroid Association (ATA) announces a new ATA award recognizing and celebrating the work of young women that are leading outstanding thyroid research, Women Advancing Thyroid Research (WATR) Award.  Sponsored by our publisher Mary Ann Liebert (https://home.liebertpub.com/) through the Rosalind Franklin Society (https://www.

• share
• favorite_border

October 31, 2019—The American Thyroid Association (ATA) is pleased to announce that the 2019 Paul Starr Award recipient and lecturer is Dr. Douglas S. Ross Professor of Medicine at Harvard Medical School and Co-Director of Thyroid Associates at Massachusetts General Hospital in Boston, Massachusetts.The Paul Starr Award is presented to an outstanding contributor to clinical thyroidology.

• share
• favorite_border

The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019, at the Sheraton Grand Chicago in Chicago, Illinois. In addition to hearing major speeches and awards, attendees can view the following oral presentations on thyroid hormone action, metabolism, and regulation.###The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.

• share
• favorite_border

The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019, at the Sheraton Grand Chicago in Chicago, Illinois. In addition to hearing major speeches and awards, attendees can view the following poster and oral presentations on autoimmunity.###The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.

• share
• favorite_border

The American Thyroid Association (ATA) announces with pleasure that Elizabeth Pearce, MD, MSc, began a one-year term as president of the Board of Directors at the close of the Annual Meeting, October 7 in Washington, DC. Dr. Pearce has served for the past year as President-Elect. Newly elected board members are: Martha Zeiger, MD, President-Elect Jacqueline Jonklaas, MD, Secretary-Elect Joshua Klopper, MD, Director Angela Leung, MD, MSc, Director.

• share
• favorite_border

The American Thyroid Association (ATA) announces with pleasure that the 2018 Van Meter Award has been presented to Dr. Carmelo Nucera, currently Assistant Professor in the Department of Pathology and at the Cancer Center and Cancer Research Institute of Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School. He is also an Associate Member at the Broad Institute of Harvard and MIT and Faculty member at the Center for Vascular Biology Research (CVBR) at BIDMC, which is dedicated to “improve human health by using genomics to advance our understanding of the biology and treatment of human disease, and to help lay the groundwork for a new generation of therapies.”

• share
• favorite_border

The American Thyroid Association (ATA) will hold its 88th Annual Meeting on October 3‒7, 2018, at the Marriott Marquis in Washington, DC. In addition to the major speeches and awards, a variety of smaller presentations will be accessible to attendees in the form of posters and oral abstracts. One group of these concerns disorders of thyroid function.

• share
• favorite_border

The American Thyroid Association (ATA) will hold its 88th Annual Meeting on October 3‒7, 2018, at the Marriott Marquis in Washington, DC. In addition to the major speeches and awards, a variety of smaller presentations will be accessible to attendees in the form of posters and oral abstracts. One group of these regards thyroid cancer.

• share
• favorite_border

The American Thyroid Association (ATA) will hold its 88th Annual Meeting on October 3‒7, 2018, at the Marriott Marquis in Washington, DC. In addition to the major speeches and awards, a variety of smaller presentations will be accessible to attendees in the form of posters and oral abstracts. One group of these regards thyroid nodules and goiters.

• share
• favorite_border

The Braverman Distinguished Award is presented annually to an individual who: demonstrates excellence and passion for mentoring fellows, students, and junior faculty; has a long history of productive thyroid research; and is devoted to the ATA. The American Thyroid Association (ATA) announces with pleasure that the 2018 Lewis E. Braverman Distinguished Award recipient will be Dr. R. Michael Tuttle, currently Clinical Director of the Endocrinology Service and Attending Physician at Memorial Hospital for Cancer and Allied Diseases in New York City.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that the 2018 Paul Starr Award recipient and lecturer will be Dr. Scott A. Rivkees, Professor and Chair, as well as Nemours Eminent Scholar, at the University of Florida Department of Pediatrics. Dr. Rivkees is also Physician-in-Chief at Shands Children’s Hospital in Gainesville, Academic Chair of Pediatrics at Arnold Palmer Hospital in Orlando, and University of Florida Chair of Pediatrics at Studer Family Children’s Hospital at Sacred Heart in Pensacola. The Starr Award is presented to an outstanding contributor to clinical thyroidology. At the ATA Annual Meeting in Washington, DC, Dr. Rivkees will deliver the Paul Starr Award Lecture at 1:00 pm on October 4, 2018, on “Unmasking the Problems With Antithyroid Medication Safety.”

• share
• favorite_border

.The 88th Annual Meeting of the American Thyroid Association (ATA) is to be held October 3-7, 2018 at the Marriott Marquis Washington DC. This year the program committee, comprised of experts of all thyroid disciplines, has developed a program featuring the latest advances in basic/ translational and clinical thyroidology (www.thyroid.org). Meeting registration is on track to generate the highest attendance we have ever had for an ATA meeting. Washington, DC is a world-class destination with many stellar cultural, musical and museum attractions (within walking distance of the headquarters’ hotel) available to attendees and their families.

• share
• favorite_border

The American Thyroid Association (ATA) announces with pleasure that the 2018 John B. Stanbury Thyroid Pathophysiology Medal will be awarded to Dr. Marvin C. Gershengorn at the ATA Annual Meeting this week. Dr. Gershengorn is Chief of the Clinical Endocrinology Branch (formerly the Laboratory of Endocrinology and Receptor Biology) at the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that the 2018 Sidney H. Ingbar Distinguished Lectureship Award recipient will be Dr. Anthony N. Hollenberg, currently the Sanford I. Weill Chair, Weill Department of Medicine, Weill Cornell Medicine and Physician-in Chief, NewYork-Presbyterian - Weill Cornell Medical Center. Dr. Hollenberg is former Chief of Endocrinology, Diabetes and Metabolism Beth Israel Deaconess Medical Center and Professor of Medicine, Harvard Medical School. The Ingbar Award recognizes an established investigator who has made outstanding contributions to thyroid-related research over many years. The award honors the memory of Dr. Sidney H. Ingbar, a brilliant innovator who was once Chief of the Beth Israel Thyroid Unit, a position Dr. Hollenberg recently held. The award is conferred at the ATA Annual Meeting, held this year from October 3 to 7 in Washington, DC. On Friday, October 5, at 1 pm, Dr. Hollenberg will deliver the Sidney H. Ingbar Disti

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that the 2018 Distinguished Service Award recipient will be Dr. David H. Sarne, currently Clinical Associate in the Department of Medicine at the University of Chicago.

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Ann-Kathrin Eisfeld, MD, Clinical Fellow in Internal Medicine at Ohio State University. The topic of Dr. Eisfeld’s project is “Novel NRAS isoform mediates BRAF-inhibitor resistance in papillary thyroid cancer—thinking outside the box to overcome ‘inevitable’ treatment failure.” Papillary thyroid cancer (PTC) is one of the 10 most common malignancies in the United States, with almost 60,000 new people diagnosed each year. While almost all patients initially respond well to the current standard treatment with radioactive iodine, almost half of them will eventually develop resistance. Therapies that can provide additional treatment options for those patients are greatly needed.

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Cintia Eliana Citterio, PhD, Assistant Professor of Genetics and Molecular Biology at the Instituto de Inmunología, Genética y Metabolismo (INIGEM), Universidad de Buenos Aires (UBA) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Dr. Citterio’s project is called “De novo triiodothyronine (T3) formation in T3 toxicosis of Graves’ Disease.” The project focuses on identifying T3-forming sites in thyroglobulin (TG, the protein from which thyroid hormone is made) that are responsible for excess T3 production in patients with autoimmune hyperthyroidism or Graves’ Disease (GD).

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Nicholas J. Tardi, PhD, Instructor in Internal Medicine at Rush University Medical Center in Chicago. Dr. Tardi’s project is titled “Deiodinase 3: A Thyroid Hormone-Associated Renoprotective Protein.” The long-term goal of this project is to identify the source and mechanism of kidney and thyroid comorbidity. Thyroid hormone (TH) is a circulating, lipid-soluble molecule that plays an important physiological and developmental role in nearly all cells. Accordingly, precise control of TH activity is crucial to maintain metabolic homeostasis in several tissues.

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Wayne Miles, PhD, Assistant Professor of Molecular Genetics at the Ohio State University. Dr. Miles’s research project is entitled “Proteomic-led discovery of essential genes in Medullary Thyroid Cancer.” Medullary thyroid cancer (MTC) is caused by the malignant growth of C-cells. Although MTC represents only a small fraction (2¬4%) of all thyroid cancer cases and overall survival rates from MTC are good, patients diagnosed with advanced disease have poor five-year survival rates (28%). The genetic aberrations of the cancer result in C-cells receiving a continuous signal to grow and proliferate. To sustain their elevated growth rates, MTC cells adapt their genome (DNA), transcriptome (RNA), and proteome (the entire set of proteins expressed by a cell, tissue, or organism).

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Miles Miller, PhD, principal investigator at the Massachusetts General Hospital Center for Systems Biology and Assistant Professor of Radiology at Harvard Medical School. Dr. Miller’s research project is titled “Co-opting tumor-associated macrophages in anaplastic thyroid cancer to enhance immune-checkpoint blockade response.” Treatment of advanced metastatic cancer has seen a revolution over the last several years, as new therapeutic strategies have become successful at harnessing the power of the immune system to durably attack malignant and mutated cancer cells. Immune-checkpoint blockade therapies targeting programmed-death 1 (PD1) signaling on T-cells have been successful in the treatment of solid cancers, including heavily mutated melanomas and lung cancers. Unfortunately, these treatments only work in a fraction of patients, and resistance is often associated with the presence of a type of tumor-promoting imm

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Stephanie Behringer-Massera, MD, Clinical Fellow at the Icahn School of Medicine at Mount Sinai. Dr. Behringer-Massera’s project is titled “T regulatory cells in thyroid-antibody-positive pregnant women.” A fetus, which shares half its genetic material with the father, is considered a foreign body in the mother’s womb. The only way that it can implant in the uterus without being rejected is if the mother’s immune system is suppressed, which happens through T-regulatory-cell action. The more T regulatory cells (Tregs) are released, the more the immune system is suppressed and the more likely the pregnancy can successfully be brought to term. In women with autoimmune thyroid disease, this process is disrupted. These women are found to have an abnormal Treg response to pregnancy and have Treg levels as low as women who are not pregnant. They are more likely to have miscarriages in the first trimester.

• share
• favorite_border

The American Thyroid Association has awarded a 2018 Research Grant to Brendan Frett, PhD, Assistant Professor in the College of Pharmacy at the University of Arkansas for Medical Sciences. The title of Dr. Frett’s project is “Dual Inhibition of RET and Aurora B to Study the Simultaneous Regulation of Multiple Oncogene Pathways in Medullary Thyroid Cancer.” Since its inception in 1971, the War on Cancer has resulted in significant treatment breakthroughs. One of the most important was the discovery of cancer-promoting oncogenes (genes with the potential to cause cancer). Researchers theorized that oncogenes could be strategically targeted while sparing normal cells, which sparked the era of precision medicine for oncology. Early medicine discoveries were quickly followed by the realization that secondary mutations in cancers often resulted in resistance to the drugs and relapse of the disease. This was solved by generating inhibitors that achieved activity on multiple forms of the onc

• share
• favorite_border

The American Thyroid Association (ATA®) is pleased to announce that Dr. Angela M. Leung has been selected as the new Editor-in-Chief of the ATA monthly journal Clinical Thyroidology®, as of 2019. Clinical Thyroidology is one of the ATA official journals distributed electronically. This highly valued abstract and commentary publication provides a broad-ranging look at the clinical thyroid literature. Experts in the field summarize the most cutting-edge, relevant articles of which clinicians should be aware and provide insight into the relevance and impact of each article on patient care.

• share
• favorite_border

In the spring of 2017, 12,146 individuals with hypothyroidism responded to an online survey posted on a variety of websites and social media for two months by the Program Committee of the Satellite Symposium on Hypothyroidism, organized by the American Thyroid Association (ATA). The ATA Hypothyroidism Treatment Survey asked responders to answer questions about demographic data, their satisfaction with treatments and their physicians, their perceptions of the physicians’ knowledge about hypothyroidism treatments, the need for new treatments, and the impact of hypothyroidism on their lives, among others.

• share
• favorite_border

American Thyroid Association calls for pre-distribution of potassium iodide (KI) to individual households residing within a minimum of the 10-mile emergency planning zone (EPZ). The ATA® also calls for maintenance of a stockpile of potassium iodine in a greater than 10 out to 50-mile ring out from nuclear power points.

• share
• favorite_border

At the American Thyroid Association Annual Meeting, Dr. Haymart discussed the controversies in the treatment of low-risk differentiated thyroid cancer and the implications for clinicians and patients alike.

• share
• favorite_border

The American Thyroid Association (ATA) announces election results.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that the 2017 Van Meter Award recipient is Megan R. Haymart, MD.

• share
• favorite_border

The ATA is proud to announce that William B. Inabnet, III, MD, will take over the helm of the video-journal at the beginning of 2018.

• share
• favorite_border

In addition to the major talks and awards at ATA's 87th Annual Meeting, a variety of scientific and clinical presentations will be accessible to attendees in the form of posters and oral abstracts.